← Back to patent-cliff list
CAS 3144-09-0
methanesulfonamide
Codes：DASA-028
Application context (from source-drug indications)
慢性丙型肝炎达塞布韦钠丙型肝炎达塞布韦钠失代偿性肝硬化达塞布韦钠肾功能不全达塞布韦钠纤维化达塞布韦钠终末期肾脏病达塞布韦钠
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 达塞布韦钠Dasabuvir Sodium Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(tert-butyl)phenol→2-(tert-butyl)-4,6-diiodophenol→1-(tert-butyl)-3,5-diiodo-2-methoxybenzene→pyrimidine-2,4(1H,3H)-dione→1-(3-(tert-butyl)-5-iodo-4-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione→(6-hydroxynaphthalen-2-yl)boronic acid→1-(3-(tert-butyl)-5-(6-hydroxynaphthalen-2-yl)-4-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione→6-[3-Tert-Butyl-5-(2,4-Dioxo-3,4-Dihydropyrimidin-1(2H)-Yl)-2-Methoxyphenyl]-2-Naphthyl 1,1,2,2,3,3,4,4,4-Nonafluorobutane-1-Sulfonate→methanesulfonamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.